Constitutive session of the Supervisory Board of Krka, d. d., Novo mesto - komunikat spółki KRKA, TOVARNA ZDRAVIL D.D. (krka) - komunikat ESPI

2025-09-18 08:17:08

Komunikat spółki

COMMON REPORT


POLISH FINANCIAL SUPERVISION AUTHORITY

		UNI - EN REPORT No		39	/	2025

Date of issue:	2025-09-18

Short name of the issuer
KRKA

Subject
Constitutive session of the Supervisory Board of Krka, d. d., Novo mesto

Official market - legal basis
Art. 17 ust. 1 MAR

Unofficial market - legal basis


Contents of the report:
In accordance with the Ljubljana Stock Exchange Rules and Article 130 of the Market in Financial Instruments Act, company Krka, d. d., Novo mesto hereby publishes the following notice: At its constitutive session held on 17 September 2025, the Supervisory Board of Krka, d. d., Novo mesto elected Jože Mermal as a President of the Supervisory Board and prof. dr. Juliana Kristl as a Deputy President, shareholder representative. Second Deputy President of the Supervisory Board, a representative of employees, is dr. Mateja Vrečer, elected in June 2024. The notice will be published on the Company's website (www.krka.biz) from 18 September 2025 onwards, for a minimum period of 5 years.

Annexes
File			Description

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)


SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2025-09-18	Jože Colarič	President of the Management Board and CEO

Źródło: strona internetowa spółki, relacje inwestorskie, raporty bieżące i okresowe.